Growth in the human augmentation sector won't happen equally. Whoever redefines this market will capture the lion's share of the $1.8 billion in profits up for grabs.
- The 3 Best Penny Stocks to Buy and Hold in 2016
- Ekso Bionics: Now the First and Only FDA-Approved Exoskeleton
- Ekso Bionics – 33 Million Strides Taken to Corner a $2.1 Billion Market
- EKSO Stock Price Prediction Shows 1,676% Profit Potential
- This Little-Known Industry Is Producing the Fastest-Growing Stocks
- Score an Extra 655% with EKSO – Make Your Move Now
- Why Ekso Bionics (OTCbb: EKSO) Stock Is a Long-Term Profit Machine
- Top Stock Picks: An Inspirational Company with 1,400% Upside Potential
- My New Price Projection for Ekso Bionics (EKSO)
- "Unloved" Pick of the Week: Ekso Bionics (OTC: EKSO) Stock
- This Play Could Double Again – But There's Much More to It
- Today's Best Tech Investment Is the Most Inspirational Company I've Ever Visited
No company captures the imagination the way Ekso Bionics Holdings Inc. (OTCBB: EKSO) does.
The tiny exoskeleton maker just reported earnings and, as you might expect, there's broad-based growth in every metric that matters.
But there's something the media isn't covering.
Ironically, it's the single most important factor in what I believe will ultimately be an exceptionally bright future for the company and savvy investors alike.
Ekso Bionics Holding (OTCBB: EKSO) stock has dipped 41% in the last three months and currently trades near $1.23 per share.
But EKSO stock is a still a long-term buy. In fact, this little-known stock has a profit potential of up to 1,676% in the next five years.
Money Morning’s Chief Investment Strategist Keith Fitz-Gerald first told his readers about the incredible profit opportunity in the human augmentation market in October 2014.
Since then, it has provided some of the fastest-growing stocks on the market. And Fitz-Gerald sees the run continuing for years.
“No matter how many times I review the data or I rearrange the puzzle, this is THE trend of the next decade,” Fitz-Gerald said.
We've loved EKSO Bionics for some time now. It's revenue has gone up 80% since we first recommended it. Its exports surged 250% in one year.
And Sterne Agee kicked off coverage of the company with a "buy" rating and an initial price target of $1.75 per share.
Ekso Bionics Holdings Inc. (OTCbb: EKSO) stock is one of the best long-term profit plays on the market today.
In fact, our experts say EKSO stock could climb 1,648% from today's opening price within the next five years.
As part of his research process, Fitz-Gerald visited the small Richmond, Calif., company in 2014. The technology he saw was a total game-changer.
Start the conversation
When Money Morning's Chief Investment Strategist Keith Fitz-Gerald first recommended one of his top stock picks in October, he set a growth estimate of 1,358%.
But he's making a correction. That initial estimate was just too low.
Fitz-Gerald now sees this stock climbing 1,417%. The tech stock opened today at just $1.44 per share. But by 2020, Fitz-Gerald sees it climbing to $21.85 per share.
Ekso Bionics is a cutting-edge company. Last October, we reported that its share price would go up to $21.14 by 2020.
But based on what EKSO is currently doing, and what's happening in the broader market, we've grown even more bullish on the stock.
Money Morning's "unloved" pick of the week is robotic exoskeleton company Ekso Bionics Holdings Inc. (OTC: EKSO).
Ekso stock is a favorite pick of Money Morning Chief Investment Strategist Keith Fitz-Gerald. He believes Ekso Bionics stock could rise more than 13-fold over the next five years.
As a penny stock that keeps losing money, Ekso quickly fell out of favor with investors after a wildly successful IPO. Usually that's a bad sign.
A big grin lit up my face when I opened my trading screens recently.
I was looking at the chart for Ekso Bionics. The company was trading at right around $1.81 per share at midday on Monday.
That means it was close to a double from where I initially recommended it as our first human augmentation target to members of my Total Wealth research service.
Ekso is still a great buy, which is why I'm recommending it for Money Morning, too. There's plenty of room for this company to double - again.
The best tech investment to make today centers around some jaw-dropping technology - and I had the chance to see it firsthand.
You see, if I'm going to recommend an investment, I'd better have a good idea of what the company does and how they do it. And you can't find that on a website. So I was excited about my recent visit to a small firm to dig up the details on our unstoppable "human augmentation" trend.